José María
Pego Reigosa
Hospital de Gran Canaria Dr. Negrin
Las Palmas de Gran Canaria, EspañaPublicacións en colaboración con investigadores/as de Hospital de Gran Canaria Dr. Negrin (44)
2024
-
Diffuse alveolar hemorrhage in patients with systemic lupus erythematosus: data from the Spanish society of rheumathology Lupus Register (RELESSER)
Rheumatology International, Vol. 44, Núm. 11, pp. 2445-2455
-
Does remission in systemic lupus erythematosus according to the 2021 DORIS definition match the treating rheumatologist's judgement?
Rheumatology (Oxford, England), Vol. 63, Núm. 1, pp. 72-78
-
Multidisciplinary consensus on the use of hydroxychloroquine in patients with systemic lupus erythematosus
Reumatologia Clinica, Vol. 20, Núm. 6, pp. 312-319
-
SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort
Lupus Science and Medicine, Vol. 11, Núm. 1
2023
-
Central nervous system involvement in systemic lupus erythematosus: Data from the Spanish Society of Rheumatology Lupus Register (RELESSER)
Seminars in Arthritis and Rheumatism, Vol. 58
-
Does expert opinion match the definition of lupus low disease activity state? Prospective analysis of 500 patients from a Spanish multicentre cohort
Rheumatology (Oxford, England), Vol. 62, Núm. 3, pp. 1162-1169
-
Pregnancy outcomes in 1869 pregnancies in a large cohort from the Spanish Society of Rheumatology Lupus Register (RELESSER)
Seminars in Arthritis and Rheumatism, Vol. 61
2022
-
Antimalarials exert a cardioprotective effect in lupus patients: Insights from the Spanish Society of Rheumatology Lupus Register (RELESSER) analysis of factors associated with heart failure
Seminars in Arthritis and Rheumatism, Vol. 52
-
Clinical characteristics and risk factors associated with lymphoma in patients with systemic lupus erythematosus: a nationwide cohort study
Rheumatology (Oxford, England), Vol. 62, Núm. 1, pp. 217-224
-
Myo-Spain: Spanish Registry of Patients with Idiopathic Inflammatory Myopathy. Methodology
Reumatologia Clinica, Vol. 18, Núm. 5, pp. 253-259
-
Recommendations for prevention of infection in systemic autoimmune rheumatic diseases
Reumatologia Clinica, Vol. 18, Núm. 6, pp. 317-330
2021
-
Comorbidities (excluding lymphoma) in Sjögren's syndrome
Rheumatology (United Kingdom), Vol. 60, Núm. 5, pp. 2075-2084
-
Contributions of the lupus register of the Spanish Society of Rheumatology (RELESSER) to the knowledge of systemic lupus erythematosus in Spain
Reumatologia Clinica, Vol. 17, Núm. 5, pp. 245-249
-
Do all antiphospholipid antibodies confer the same risk for major organ involvement in systemic lupus erythematosus patients?
Clinical and Experimental Rheumatology, Vol. 39, Núm. 3, pp. 555-563
-
European League against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance
Annals of the Rheumatic Diseases, Vol. 80, Núm. 6, pp. 775-781
-
Late-onset versus early-onset systemic lupus: characteristics and outcome in a national multicentre register (RELESSER)
Rheumatology (Oxford, England), Vol. 60, Núm. 4, pp. 1793-1803
-
Relevance of gastrointestinal manifestations in a large Spanish cohort of patients with systemic lupus erythematosus: what do we know?
Rheumatology (Oxford, England), Vol. 60, Núm. 11, pp. 5329-5336
-
Role of targeted therapies in rheumatic patients on COVID-19 outcomes: Results from the COVIDSER study
RMD Open, Vol. 7, Núm. 3
-
What are the topics you care about making trials in lupus more effective? Results of an Open Space meeting of international lupus experts
Lupus Science and Medicine, Vol. 8, Núm. 1